Product methodology

Dialysis Center Mortality and Hospitalization Surveillance

Source contract, normalization path, entity-graph join, refresh posture, and publication limits for this Branmoor product.

Status

In service. This product has a functional preview or paid engagement surface in the current site. The full licensed product may still include private exports, alerts, APIs, or buyer-specific diligence that are not exposed publicly.

Distribution Scope

Nationwide; TN dialysis layer; Nashville dialysis facilities

Product Question

Tracks dialysis mortality, hospitalization, survey, water, and ownership risk.

Primary Sources

CMS Dialysis Facility Compare — Facility-level quality measures, adjusted mortality, hospitalization
CMS ESRD claims (CCW) — Granular utilization and outcomes
EPA water quality records — Source water violations affecting dialysis safety
CMS Conditions for Coverage survey deficiencies — Facility regulatory citations
Ownership and management company records — DaVita, Fresenius, and independent operator distinctions

Entity-Graph Join

dialysis `ccn`, owner `irs_ein`, `pws_id`, county/tract.

Publication Rule

Branmoor does not treat raw public records as the product. A surface is publishable only when the source record is dated, normalized, source-linked, and joined to the relevant Branmoor entity identifiers with enough confidence to state the limits of the result.

Current Methodology Note

Mortality is risk-adjusted using the CMS standardized methodology. The preview register shows every U.S. facility with its CMS-published Better/As Expected/Worse classification on mortality, hospitalization, transfusion, infection, and transplant waitlisting. The licensed product layers DUA-gated ESRD claims, EPA water-quality cross-reference, and metropolitan-area peer comparison.

Limits

Coverage follows the underlying source. Missing state portals, gated APIs, PDF-only filings, suppressed fields, lagged agency refreshes, and entity-name ambiguity can all limit product completeness. Pending products are not marketed as live until those limits are documented on the product surface.

‹ Dialysis Center Mortality and Hospitalization Surveillance · All products